RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SPERLI F
Collezione AOU San Luigi di Orbassano

Items : 10

Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Sep;77:104893. doi: 10.1016/j.msard.2023.104893. Epub 2023 Jul 16.

2023
AOU San Luigi di Orbassano

Valentino P; Malucchi S; Bava CI; Martire S; Capobianco M; Malentacchi M; Sperli F; Oggero A; Di Sapio A; Bertolotto A;

Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study. in Neurology and therapy / Neurol Ther. 2023 Aug;12(4):1375-1383. doi: 10.1007/s40120-023-00481-w. Epub 2023 May 11.

2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Capobianco MA; Pautasso M; Bertolotto A; Valentino P; Martire S; Sala A; Sperli F; Malentacchi M; Malucchi S; Bruschi N;

Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2020 Oct;26(12):1519-1531. doi: 10.1177/1352458519872889. Epub 2019 Oct 1.

2020
ASL Cuneo 1
AOU San Luigi di Orbassano

Gobbi C; Uccelli A; Signori A; Amato MP; Granella F; Barilaro A; Abbadessa G; Fenu G; Brescia Morra V; Prestipino E; Sperli F; Magnani E; Lorefice L; De Angelis M; Malentacchi M; Cellerino M; Gallo A; Sacco R; Mechi C; Salemi G; Coghe G; Nozzolillo A; Malucchi S; Boffa G; Maraffi I; Maietta I; Barone S; Maniscalco GT; Di Sapio A; et alii...

High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study. in Neurology and therapy / Neurol Ther. 2017 Jun;6(1):145-152. doi: 10.1007/s40120-016-0058-0. Epub 2016 Dec 3.

2017
AOU San Luigi di Orbassano

Malucchi S; Capobianco M; Lo Re M; Malentacchi M; di Sapio A; Matta M; Sperli F; Bertolotto A;

Normative Values for Intertrial Variability of Motor Responses to Nerve Root and Transcranial Stimulation: A Condition for Follow-Up Studies in Individual Subjects. in PloS one / PLoS One. 2016 May 16;11(5):e0155268. doi: 10.1371/journal.pone.0155268. eCollection 2016.

2016
AOU San Luigi di Orbassano

Troni W; Melillo F; Bertolotto A; Malucchi S; Capobianco M; Sperli F; Di Sapio A;

No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab discontinuation. in European journal of neurology / Eur J Neurol. 2015 Mar;22(3):585-7. doi: 10.1111/ene.12487. Epub 2014 Jul 3.

2015
AOU San Luigi di Orbassano

Capobianco M; di Sapio A; Malentacchi M; Malucchi S; Matta M; Sperli F; Bertolotto A;

A new neurophysiological approach to assess central motor conduction damage to proximal and distal muscles of lower limbs. in Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology / Clin Neurophysiol. 2014 Jan;125(1):133-41. doi: 10.1016/j.clinph.2013.06.018. Epub 2013 Jul 16.

2014
AOU San Luigi di Orbassano

Di Sapio A; Bertolotto A; Melillo F; Sperli F; Malucchi S; Troni W; Di Sapio A; Bertolotto A; Melillo F; Sperli F; Malucchi S; Troni W;

A methodological reappraisal of non invasive high voltage electrical stimulation of lumbosacral nerve roots. in Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology / Clin Neurophysiol. 2011 Oct;122(10):2071-80. doi: 10.1016/j.clinph.2011.03.002. Epub 2011 Mar 31.

2011
AOU San Luigi di Orbassano

Troni W; Di Sapio A; Berra E; Duca S; Merola A; Sperli F; Bertolotto A;

Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. in PloS one / PLoS One. 2010 Jan 29;5(1):e8962. doi: 10.1371/journal.pone.0008962.

2010
AOU San Luigi di Orbassano

Gilli F; Lindberg RL; Valentino P; Marnetto F; Malucchi S; Sala A; Capobianco M; di Sapio A; Sperli F; Kappos L; Calogero RA; Bertolotto A;

Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patients. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2008 Sep;29 Suppl 2:S227-9. doi: 10.1007/s10072-008-0945-y.

2008
AOU San Luigi di Orbassano

Capobianco M; Rizzo A; Malucchi S; Sperli F; Di Sapio A; Oggero A; Zaffaroni M; Ghezzi A; Bertolotto A;